OBJECTIVES: Our goal was to prospectively compare the accuracy of real-time three-dimensional (3D) color Doppler vena contracta (VC) area and two-dimensional (2D) VC diameter in an in vitro model and in the clinical assessment of mitral regurgitation (MR) severity. BACKGROUND: Real-time 3D color Doppler allows direct measurement of VC area and may be more accurate for assessment of MR than the conventional VC diameter measurement by 2D color Doppler. METHODS: Using a circulatory loop with an incorporated imaging chamber, various pulsatile flow rates of MR were driven through 4 differently sized orifices. In a clinical study of patients with at least mild MR, regurgitation severity was assessed quantitatively using Doppler-derived effective regurgitant orifice area (EROA), and semiquantitatively as recommended by the American Society of Echocardiography. We describe a step-by-step process to accurately identify the 3D-VC area and compare that measure against known orifice areas (in vitro study) and EROA (clinical study). RESULTS: In vitro, 3D-VC area demonstrated the strongest correlation with known orifice area (r = 0.92, p < 0.001), whereas 2D-VC diameter had a weak correlation with orifice area (r = 0.56, p = 0.01). In a clinical study of 61 patients, 3D-VC area correlated with Doppler-derived EROA (r = 0.85, p < 0.001); the relation was stronger than for 2D-VC diameter (r = 0.67, p < 0.001). The advantage of 3D-VC area over 2D-VC diameter was more pronounced in eccentric jets (r = 0.87, p < 0.001 vs. r = 0.6, p < 0.001, respectively) and in moderate-to-severe or severe MR (r = 0.80, p < 0.001 vs. r = 0.18, p = 0.4, respectively). CONCLUSIONS: Measurement of VC area is feasible with real-time 3D color Doppler and provides a simple parameter that accurately reflects MR severity, particularly in eccentric and clinically significant MR where geometric assumptions may be challenging.
OBJECTIVES: Our goal was to prospectively compare the accuracy of real-time three-dimensional (3D) color Doppler vena contracta (VC) area and two-dimensional (2D) VC diameter in an in vitro model and in the clinical assessment of mitral regurgitation (MR) severity. BACKGROUND: Real-time 3D color Doppler allows direct measurement of VC area and may be more accurate for assessment of MR than the conventional VC diameter measurement by 2D color Doppler. METHODS: Using a circulatory loop with an incorporated imaging chamber, various pulsatile flow rates of MR were driven through 4 differently sized orifices. In a clinical study of patients with at least mild MR, regurgitation severity was assessed quantitatively using Doppler-derived effective regurgitant orifice area (EROA), and semiquantitatively as recommended by the American Society of Echocardiography. We describe a step-by-step process to accurately identify the 3D-VC area and compare that measure against known orifice areas (in vitro study) and EROA (clinical study). RESULTS: In vitro, 3D-VC area demonstrated the strongest correlation with known orifice area (r = 0.92, p < 0.001), whereas 2D-VC diameter had a weak correlation with orifice area (r = 0.56, p = 0.01). In a clinical study of 61 patients, 3D-VC area correlated with Doppler-derived EROA (r = 0.85, p < 0.001); the relation was stronger than for 2D-VC diameter (r = 0.67, p < 0.001). The advantage of 3D-VC area over 2D-VC diameter was more pronounced in eccentric jets (r = 0.87, p < 0.001 vs. r = 0.6, p < 0.001, respectively) and in moderate-to-severe or severe MR (r = 0.80, p < 0.001 vs. r = 0.18, p = 0.4, respectively). CONCLUSIONS: Measurement of VC area is feasible with real-time 3D color Doppler and provides a simple parameter that accurately reflects MR severity, particularly in eccentric and clinically significant MR where geometric assumptions may be challenging.
Authors: Y Mori; T Shiota; M Jones; S Wanitkun; T Irvine; X Li; A Delabays; N G Pandian; D J Sahn Journal: Circulation Date: 1999-03-30 Impact factor: 29.690
Authors: D Mele; P Vandervoort; I Palacios; J M Rivera; R E Dinsmore; E Schwammenthal; J E Marshall; A E Weyman; R A Levine Journal: Circulation Date: 1995-02-01 Impact factor: 29.690
Authors: Paul A Grayburn; Lilin She; Brad J Roberts; Krzysztof S Golba; Krzysztof Mokrzycki; Jaroslaw Drozdz; Alexander Cherniavsky; Roman Przybylski; Krzysztof Wrobel; Federico M Asch; Thomas A Holly; Haissam Haddad; Michael Yii; Gerald Maurer; Irving Kron; Hartzell Schaff; Eric J Velazquez; Jae K Oh Journal: Am J Cardiol Date: 2015-06-25 Impact factor: 2.778
Authors: Ilonka Rohm; Tudor C Poerner; Ali Hamadanchi; Sylvia Otto; Torsten Doenst; Christian Jung; P Christian Schulze; Björn Goebel Journal: Int J Cardiovasc Imaging Date: 2017-05-11 Impact factor: 2.357
Authors: Ashwin Prakash; Ronald V Lacro; Lynn A Sleeper; L Luann Minich; Steven D Colan; Brian McCrindle; Wesley Covitz; Fraser Golding; Anthony M Hlavacek; Jami C Levine; Meryl S Cohen Journal: Pediatr Cardiol Date: 2011-09-10 Impact factor: 1.655
Authors: Chaim Yosefy; Judy Hung; Sarah Chua; Mordehay Vaturi; Thanh-Thao Ton-Nu; Mark D Handschumacher; Robert A Levine Journal: Am J Cardiol Date: 2009-10-01 Impact factor: 2.778